paclitaxel has been researched along with Carcinoma, Mucoepidermoid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, J; Guo, Z; Li, X; Liu, J; Ren, D; Wei, S; Xu, S | 1 |
| Ikura, Y; Inoue, K; Kawaguchi, T; Maeda, T; Moritaka, T; Nakanishi, N; Shiojiri, M; Sonobe, S; Tachibana, S | 1 |
| Adams, A; McLean, SA; Misawa, K; Mochizuki, D; Nör, JE; Pearson, AT; Warner, KA; Wolf, GT; Zhang, Z | 1 |
| Balboni, TA; Haddad, RI; Norris, CM; Posner, MR; Schoenfeld, JD; Sher, DJ; Tishler, RB | 1 |
| Cai, BL; Fu, SM; Guan, SM; Shen, LL; Wu, JZ; Xu, XF; Zhang, J | 1 |
| Forastiere, AA; Gilbert, J; Jennings, T; Kies, MS; Li, Y; Pinto, HA; Silverman, P | 1 |
1 trial(s) available for paclitaxel and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salivary Gland Neoplasms | 2006 |
5 other study(ies) available for paclitaxel and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
Clinicopathological characteristics and molecular analysis of primary pulmonary mucoepidermoid carcinoma: Case report and literature review.
Topics: Aged; Carboplatin; Carcinoma, Mucoepidermoid; Disease-Free Survival; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome | 2018 |
A case of pulmonary mucoepidermoid carcinoma responding to carboplatin and paclitaxel.
Topics: Antineoplastic Agents; Bronchial Neoplasms; Carboplatin; Carcinoma, Mucoepidermoid; Disease-Free Survival; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Tracheal Neoplasms; Treatment Outcome | 2014 |
Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; Humans; Interleukin-6; Mice; Mice, SCID; Paclitaxel; Phosphorylation; Random Allocation; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2015 |
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Chemoradiotherapy; Dermatitis; Disease-Free Survival; Esophagitis; Female; Humans; Male; Middle Aged; Mucositis; Paclitaxel; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salivary Gland Neoplasms; Xerostomia | 2012 |
Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Blotting, Western; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Antibody Technique, Indirect; Fluorouracil; Humans; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Salivary Gland Neoplasms | 2011 |